01694nas a2200673   4500000000100000000000100001000000100002008004100003653001100044653001400055653001100069653000900080653002600089653001800115653001500133653002000148653001700168653003200185653001600217653001900233653003400252653002500286653001700311653001800328100001900346700002300365700001300388700001600401700001100417700001600428700001800444700002100462700001100483700001500494700001600509700001800525700001200543700001500555700001200570700001600582700001400598700001300612700001300625700001200638700001900650700002100669700001400690700001500704700001400719700002000733700001200753700002100765700002300786245016800809250001500977300000700992490000700999020001401006       2023                            d10aHumans10aPregnancy10aFemale10aAged10aRetrospective Studies10a*Polypharmacy10a*Ethnicity10aMinority Groups10aRisk Factors10aUnited Kingdom/epidemiology10aMedications10aMultimorbidity10aMultiple long-term conditions10aMultiple medications10apolypharmacy10aPrescriptions1 aA. Subramanian1 aA. Azcoaga-Lorenzo1 aA. Anand1 aK. Phillips1 aS. Lee1 aN. Cockburn1 aA. Fagbamigbe1 aC. Damase-Michel1 aC. Yau1 aC. McCowan1 aD. O'Reilly1 aG. Santorelli1 aH. Hope1 aJ. Kennedy1 aK. Abel1 aK. Eastwood1 aL. Locock1 aM. Black1 aM. Loane1 aN. Moss1 aR. Plachcinski1 aS. Thangaratinam1 aS. Brophy1 aU. Agrawal1 aZ. Vowles1 aP. Brocklehurst1 aH. Dolk1 aC. Nelson-Piercy1 aK. Nirantharakumar00aPolypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019  a2023/01/17  a210 v21  a1741-7015